Vulvar lichen sclerosus
ICD-10 N90.4 · ICD-11 EB60.0

Treatment of Vulvar Lichen Sclerosus in Children with Anogenital Lichen Sclerosus

This protocol covers the management of vulvar lichen sclerosus (ICD-11 EB60.0) specifically in children presenting with anogenital lichen sclerosus. The paediatric context shapes treatment selection, as the approach must balance effective disease control with age-appropriate safety considerations.

A topical steroid applied to the affected genital skin forms the basis of management. In children, the regimen is deliberately structured to reduce the risk of skin atrophy — the specific phasing and schedule differ from adult protocols. The complete treatment algorithm is available in the full protocol.

Clinical response is formally assessed at a scheduled review following treatment initiation.

References

DOI: 10.1111/jdv.18102

Others use the steroid daily for one month, then alternate days for one month and twice weekly for one month (this may be preferred in children to avoid skin atrophy) with review at 3 months.

View source ↗